TOP2A and hepatocellular carcinoma: It is notable that TOP2A was a widely accepted hub gene in both HCC and HBV-HCC [16, 19, 28, 29], and it was also used to establish an mRNA-based signature for prognosis prediction in HBV-HCC previously [16].